Case Study: Leading Global Biopharma Company achieves optimal oncology launch go-to-market strategy with Axtria

Sales Force Restructuring Strategy For A New Oncology Indication Launch In The US

Leading Global Biopharma Company faced the challenge of planning a successful go-to-market strategy for a new oncology indication launch in the US, including determining the right sales force size and structure for its portfolio. Axtria supported the engagement using its Promotion Response Model (PRM) and Sales Force Structure and Strategy (SFSS) expertise.

Axtria recommended the optimal sales force size and structure across multiple future market scenarios and estimated the revenue impact of each option. The result was a more efficient sales force, stronger ability to promote the company’s drug portfolio, and implementation of the recommended field structure.